Ansa Biotechnologies
The latest George Church startup says its platform technology can deliver enzymatically synthesized RNA at a commercial scale in the near future.
Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service
Premium
The University of California, Berkeley spinout hopes to stand out in the synthetic DNA race using its polymerase-nucleotide conjugation approach.
Ansa Biotechnologies Closes $68M Series A Financing
The University of California, Berkeley spinout plans to use the funding to accelerate development of its enzymatic DNA synthesis technology.
DNA Data Storage Alliance to Work on Interoperability, Industry Roadmap
Illumina, Twist Bioscience, Western Digital, and Microsoft are teaming up with others to make DNA-based data storage technologies interoperable.
Ansa Biotechnologies Raises $7.9M in Seed Funding
The funding will allow the company to accelerate development of its DNA synthesis technology, hire staff, build an R&D facility, and establish industrial partnerships.